Rick Randall, TranS1 CEO, attributed the company’s weak report to a higher rate of insurance denials for lumbar surgery due to the medical necessity and ongoing AxiaLF physician reimbursement pressures.
The company reported a net loss of $3.8 million during the third quarter of 2010, a decrease from the reported $4.8 million net loss during the third quarter of 2009.
Read the release on TranS1’s 3Q FY 2010 financial report.
Read more about TranS1:
– TranS1 Releases New System for Lumbar Fusion
– TranS1 Names New President and COO
– TranS1 Names Vice President of Research and Development
